Star Combo Pharma Ltd (S66) — Cash Flow Quality Index
Star Combo Pharma Ltd (S66) has a Cash Flow Quality Index of 1.39x as of December 2025. Operating cash flow of AU$575.23K exceeds net income of AU$413.24K, indicating high earnings quality where cash backs reported profits. Explore Star Combo Pharma Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Star Combo Pharma Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Star Combo Pharma Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see S66 operating cash flow.
Annual Cash Flow Quality Index for Star Combo Pharma Ltd (2015–2025)
Year-by-year earnings quality comparison for Star Combo Pharma Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.28x | AU$11.94 Million | AU$5.25 Million | ▲ +637.3% |
| 2024 | -0.42x | AU$-316.45K | AU$747.33K | ▼ -174.3% |
| 2017 | 0.57x | AU$932.20K | AU$1.64 Million | ▼ -20.0% |
| 2016 | 0.71x | AU$1.30 Million | AU$1.82 Million | ▲ +154.6% |
| 2015 | -1.31x | AU$-308.65K | AU$236.44K | — |